Black Rock Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,547,663 shares of ALNY stock, worth $2.72 Billion. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,547,663

Previous 9,025,007 5.79%

Holding current value

$2.72 Billion

Previous $1.35 Billion 72.01%

% of portfolio

0.05%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $74.9 Million - $129 Million	522,656 Added 5.79%	9,547,663 $2.32 Billion
Q1 2024 May 10, 2024	BUY	$146.51 - $198.2 $73.8 Million - $99.9 Million	503,892 Added 5.91%	9,025,007 $1.35 Billion
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $19.4 Million - $25.2 Million	128,111 Added 1.53%	8,521,115 $1.63 Billion
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $1.17 Million - $1.45 Million	6,842 Added 0.08%	8,393,004 $1.49 Billion
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $30.1 Million - $34.5 Million	-162,800 Reduced 1.9%	8,386,162 $1.59 Billion
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $10.9 Million - $14 Million	59,582 Added 0.7%	8,548,962 $1.71 Billion
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $152 Million - $198 Million	820,702 Added 10.7%	8,489,380 $2.02 Billion
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $831,655 - $1.39 Million	6,003 Added 0.08%	7,668,678 $1.53 Billion
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $6.47 Million - $9.09 Million	53,721 Added 0.71%	7,662,675 $1.12 Billion
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $7.94 Million - $10.9 Million	-62,448 Reduced 0.81%	7,608,954 $1.24 Billion
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $199 Million - $262 Million	-1,249,570 Reduced 14.01%	7,671,402 $1.3 Billion
Q3 2021 Nov 09, 2021	BUY	$169.75 - $207.73 $38.1 Million - $46.6 Million	224,569 Added 2.58%	8,920,972 $1.68 Billion
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $1.12 Billion - $1.54 Billion	8,696,403 New	8,696,403 $1.47 Billion

Others Institutions Holding ALNY

# of Institutions

721

Shares Held

111M

Call Options Held

978K

Put Options Held

881K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $35.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account